Clinical trialPhase 2

Finerenone vs placebo in premature ovarian insufficiency

NCT07815509

План 46 участниц; primary endpoint — доля женщин, у которых удастся получить ооциты при IVF в течение 24 недель.

No news refers to this card yet.

Scales

Identifiers

NCT
NCT07815509

Original sources

Details

Phase
Phase 2
Status
Not yet recruiting

A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.